Target intelligence / Profile preview

Adaptor protein complex 2 subunit alpha-2 (AP2A2)

Target
AP2A2
Molecular classification
Vesicle coat protein complex subunit, Adaptor protein complex (AP-2 complex), Endocytic machinery, Other (not a receptor, enzyme, ion channel, or transporter)
01

Overview

Adaptor protein complex 2 subunit alpha-2 (AP2A2) is a large subunit of the AP-2 heterotetrameric adaptor protein complex, which is essential for clathrin-mediated endocytosis at the plasma membrane. AP2A2 binds polyphosphoinositide lipids to position the AP-2 complex at the membrane, serving as a platform for vesicle coat formation and as an interaction hub for accessory proteins. Through cargo recognition and endocytic vesicle assembly, AP2A2 is a key regulator of cellular protein internalization, synaptic vesicle recycling in neurons, and membrane trafficking in multiple tissues. Dysregulation or genetic variation in AP2A2 has been implicated in neurodegenerative conditions such as Alzheimer’s disease, and in other pathologies related to altered endocytosis and membrane trafficking. AP2A2 is not itself a direct therapeutic target but is of interest in studies of endocytic pathway dysfunction in disease.

Other names
AP-2 complex subunit alpha-2Adaptor-related protein complex 2 subunit alpha-2Alpha-adaptin CAlpha2-adaptinClathrin assembly protein complex 2 alpha-C large chainHuntingtin yeast partner J (HYPJ)Huntingtin-interacting protein 9 (HIP9)Clathrin-associated/assembly/adaptor protein, large, alpha 2ADTABCLAPA2DKFZP564D1864Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit100 kDa coated vesicle protein CKIAA0899
02

Mechanism of action

Not applicable; AP2A2 is not a direct drug target. Its mechanism relates to endocytic vesicle coat assembly and cargo sorting. Drugs affecting endocytosis may alter AP2A2 function indirectly, but no explicit modulators are characterized.

03

Biological functions

Clathrin-mediated endocytosisProtein trafficking and sortingCargo recognition and selection for endocytosisSynaptic vesicle recyclingRegulation of membrane protein internalizationInteraction hub for endocytic accessory proteins
04

Disease associations

Neurodegenerative disease (Alzheimer’s disease: implicated with tau pathology; colocalizes with neurofibrillary tangles)Dementia and cognitive disorder links (via synaptic transmission and protein trafficking)Parkinson’s disease (involvement in synuclein trafficking and inflammation)ObesityCoronary heart diseaseChronic bronchitisNicotine withdrawalMyopathy (rare; mutations cause severe myopathy)
05

Safety considerations

No specific safety concerns or therapeutic challenges attributable to AP2A2 as a direct target, since it is not targeted by drugs. However, dysfunction impacts essential cell processes such as synaptic vesicle recycling, potentially affecting cognition and neurobiology.
06

Biomarkers

No validated biomarkers for patient selection or monitoring of efficacy linked directly to AP2A2. Genetic variation near AP2A2 is associated with altered tau pathology (biomarker for Alzheimer’s disease progression), and abnormal AP2A2 expression has been detected in neurodegenerative tissue.

Beyond the preview

Go deeper on Adaptor protein complex 2 subunit alpha-2 (AP2A2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adaptor protein complex 2 subunit alpha-2 (AP2A2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call